Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-Weight

Morgan Stanley downgrades Takeda Pharmaceutical (NYSE:TAK) from Overweight to Equal-Weight.

Morgan Stanley downgrades Takeda Pharmaceutical (NYSE:TAK) from Overweight to Equal-Weight.

Total
0
Shares
Related Posts